Cargando…
A Qualitative Signature to Identify TERT Promoter Mutant High-Risk Tumors in Low-Grade Gliomas
Background: Telomerase reverse transcriptase promoter (TERT-p) mutation has been frequently found, but associated with contrary prognosis, in both low-grade gliomas and glioblastomas. For the low-grade gliomas (Grades II-III), TERT-p mutant patients have a better prognosis than the wildtype patients...
Autores principales: | Zheng, Weicheng, Zhang, Ruolan, Huang, Ziru, Li, Jianpeng, Wu, Haonan, Zhou, Yuwei, Zhu, Jinwei, Wang, Xianlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047542/ https://www.ncbi.nlm.nih.gov/pubmed/35495630 http://dx.doi.org/10.3389/fmolb.2022.806727 |
Ejemplares similares
-
A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
por: Yan, Xiuwei, et al.
Publicado: (2022) -
Identification and Validation of a Novel Three Hub Long Noncoding RNAs With m6A Modification Signature in Low-Grade Gliomas
por: Nguyen, Quang-Huy, et al.
Publicado: (2022) -
Prognostic Potential of Secreted Modular Calcium-Binding Protein 1 in Low-Grade Glioma
por: Wang, Jing, et al.
Publicado: (2021) -
Phosphatase and Tensin Homolog Mutation in Immune Cell Infiltration and Clinicopathological Features of Low-Grade Gliomas
por: Feng, Peng, et al.
Publicado: (2020) -
Methylation and Expression of the Exercise-Related TLR1 Gene Is Associated With Low Grade Glioma Prognosis and Outcome
por: Lu, Lichun, et al.
Publicado: (2021)